b'Pursuing ourobjectivesOther activities to reach out to stakeholders included partici-pating or sponsoring events at the Canadian Science Policy Conference, Scaling Up, BIO International, AESIS Impact of Science,StandUp2Cancer,GairdnerAwards,Advancing Women in Agriculture Conference, Canadian Cancer Research Conference, Science Meets Parliament, and others.Corporate O n a corporate level, this was an exciting and impor-tant year for Genome Canada. Central to this years activities was the development of a new Strategic Vision for the organization. The year include consul-tations with the genomics community from coast to coast, with over 300 people involved in interviews, roundtables and conversations about the future of genomics and Genome Canada. We spoke with researchers, users, federal and provincial government representatives to get a picture of where genomics is today, where it is going and how Genome Canada can best sup-port Canadian research in the field. The resulting Strategic Vision will be an evergreen vision document with high-level objectives and shorter-term strategies that will be released in early 2019-20.As part of this visioning exercise, Genome Canada also launched a review of its integrated GE3LS program. An independent panel of experts led by Dr. Eric Meslin on behalf of the Science and Industry Advisory Committee conducted interviews, looked at case studies and delivered a report with recommendations to the Board of Directors in December 2018. The report under-scores the continued need for integrated GE3LS and points to its many strengths and successes while identifying important ways the program can be strengthened. The report is available on the Genome Canada website, and its recommendations are being implemented this year and in 2019-20.Genome Canada was also pleased to work with Minister Duncan and other national research organizations to develop an Equity, Diversity and Inclusion Action Plan. Genome Canada acknowl-edges that equity, diversity and inclusion (EDI) strengthen the research ecosystem, enhance research quality, and increase the social relevance and impact of research and innovation. Genome Canada recognizes that challenges remain in achieving the full participation of underrepresented groups (including women, racialized and ethnic minorities, Indigenous peoples, people with disabilities and LGBTQ2+ people) in scientific careers and is committed to identifying and overcoming barriers that may exist within its own hiring process, programs, peer-review system, and governing bodies. Genome Canada has implemented an EDI pol-icy and framework and is working to implement EDI principles throughout its calls for applications and funding guidelines. 26 Genome Canada Annual Report 2018-19'